P

Protara Therapeutics

30 employees

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

Basic info

Industry

biotechnology
biotechnology research

Sectors

Biotechnology
Metabolic Diseases
Rare Diseases
Choline Deficiency
Corporate Development
Gastrointestinal Diseases
Health Care
Non-Muscle Invasive Bladder Cancer
Short Bowel Syndrome
Therapeutics
Lymphatic Malformations
Orphan Diseases
Drug Development
Parenteral Nutrition

Date founded

2017

Funding rounds raised

P

Protara Therapeutics raised undisclosed on May 20, 2022

Investors: Red Cedar Ventures

P

Protara Therapeutics raised undisclosed on April 8, 2022

Investors: Red Cedar Ventures

FAQ